.

• Date & Time:-

• Day | Date: Friday | 13 February 2026
• Time: (From 07:00 PM to 09:30 PM)

(       1  DAY             )

• Goals & Objectives:-

• Systematically apply evidence-based diagnostic frameworks to the evaluation of patients with suspected rare metabolic bone disorders, enabling accurate differentiation between overlapping clinical presentations within the scope of current international guidelines. 

• Critically analyze and interpret complex clinical cases of hypophosphatasia, osteogenesis imperfecta, and osteomalacia/XLH by integrating clinical findings, biochemical markers, and imaging results to support precise diagnosis and appropriate management planning. 

• Differentiate between inherited and acquired metabolic bone disorders through structured case-based discussions, enhancing diagnostic accuracy and reducing the risk of misdiagnosis in routine clinical practice. 

• Demonstrate improved clinical reasoning and knowledge retention in the field of metabolic bone diseases by achieving measurable competency through interactive MCQ-based assessments aligned with the educational content delivered during the webinar. 

• Apply standardized clinical assessment approaches in a simulated OSCE format to evaluate patients with suspected bone disorders, demonstrating competency in history taking, physical examination, diagnostic prioritization, and clinical decision-making. 

•    Integrate key learning outcomes into clinical practice by synthesizing evidence-based principles discussed throughout the webinar to optimize patient care, clinical outcomes, and professional performance in endocrinology and related specialties

• Learning outcomes:-

• This educational webinar aims to systematically enhance healthcare practitioners’ ability to apply evidence-based diagnostic frameworks in the evaluation of rare metabolic bone disorders, enabling accurate differentiation between overlapping clinical presentations in accordance with current international guidelines. Through structured case-based discussions on hypophosphatasia, osteogenesis imperfecta, and osteomalacia/XLH, participants are expected to critically analyze clinical, biochemical, and imaging findings to support precise diagnosis and appropriate management planning. The activity incorporates interactive MCQ-based assessments to objectively measure knowledge acquisition and clinical reasoning, in addition to a mock OSCE-style clinical evaluation designed to assess participants’ competency in history taking, physical examination, diagnostic prioritization, and clinical decision-making. By the end of the webinar, participants are expected to integrate key learning outcomes into clinical practice, thereby improving diagnostic accuracy, patient care, and overall professional performance in the field of metabolic bone disorders. 

• Topics & Timings:-